Da: California Books, Miami, FL, U.S.A.
EUR 65,52
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condizione: new. Hardcover. This Special Issue presents preclinical and clinical research aimed at reframing the diagnosis and treatment of affective disorders beyond classical neurobiological models. It includes a meta-analysis comparing single- versus two-dose psilocybin administration in major depressive disorder, clarifying its efficacy and dose-dependency. Another study uses network analysis of exposome scores to link environmental exposure with multidimensional psychopathology in non-clinical samples, while the effects of light pollution on affective health highlight chronobiological disruption in mood disorder etiology.Diagnostic and clinical dimensions are explored through research on polarity at bipolar disorder onset, mapping temperamental correlates and long-term trajectories. Biomarker studies report elevated mature brain-derived neurotrophic factor (BDNF) levels associated with suicidal ideation in major depressive disorder and evaluate BDNF's validity in bipolar disorder. Perinatal and familial aspects are explored in a structural equation modeling study showing how attachment-related coping mediates postpartum depressive symptoms and which develops a protocol for a randomized clinical trial for a psychoeducational family intervention in major depressive disorder. Together, these contributions outline a multidimensional landscape integrating environmental, temperamental, biological, and psychosocial determinants. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Da: PBShop.store US, Wood Dale, IL, U.S.A.
EUR 64,97
Quantità: Più di 20 disponibili
Aggiungi al carrelloHRD. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
EUR 60,47
Quantità: Più di 20 disponibili
Aggiungi al carrelloHRD. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Da: Majestic Books, Hounslow, Regno Unito
EUR 88,24
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand.
Condizione: New. Print on Demand.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 88,57
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND.
Da: AussieBookSeller, Truganina, VIC, Australia
EUR 78,47
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. This Special Issue presents preclinical and clinical research aimed at reframing the diagnosis and treatment of affective disorders beyond classical neurobiological models. It includes a meta-analysis comparing single- versus two-dose psilocybin administration in major depressive disorder, clarifying its efficacy and dose-dependency. Another study uses network analysis of exposome scores to link environmental exposure with multidimensional psychopathology in non-clinical samples, while the effects of light pollution on affective health highlight chronobiological disruption in mood disorder etiology.Diagnostic and clinical dimensions are explored through research on polarity at bipolar disorder onset, mapping temperamental correlates and long-term trajectories. Biomarker studies report elevated mature brain-derived neurotrophic factor (BDNF) levels associated with suicidal ideation in major depressive disorder and evaluate BDNF's validity in bipolar disorder. Perinatal and familial aspects are explored in a structural equation modeling study showing how attachment-related coping mediates postpartum depressive symptoms and which develops a protocol for a randomized clinical trial for a psychoeducational family intervention in major depressive disorder. Together, these contributions outline a multidimensional landscape integrating environmental, temperamental, biological, and psychosocial determinants. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Da: CitiRetail, Stevenage, Regno Unito
EUR 68,27
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. This Special Issue presents preclinical and clinical research aimed at reframing the diagnosis and treatment of affective disorders beyond classical neurobiological models. It includes a meta-analysis comparing single- versus two-dose psilocybin administration in major depressive disorder, clarifying its efficacy and dose-dependency. Another study uses network analysis of exposome scores to link environmental exposure with multidimensional psychopathology in non-clinical samples, while the effects of light pollution on affective health highlight chronobiological disruption in mood disorder etiology.Diagnostic and clinical dimensions are explored through research on polarity at bipolar disorder onset, mapping temperamental correlates and long-term trajectories. Biomarker studies report elevated mature brain-derived neurotrophic factor (BDNF) levels associated with suicidal ideation in major depressive disorder and evaluate BDNF's validity in bipolar disorder. Perinatal and familial aspects are explored in a structural equation modeling study showing how attachment-related coping mediates postpartum depressive symptoms and which develops a protocol for a randomized clinical trial for a psychoeducational family intervention in major depressive disorder. Together, these contributions outline a multidimensional landscape integrating environmental, temperamental, biological, and psychosocial determinants. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 71,87
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This Special Issue presents preclinical and clinical research aimed at reframing the diagnosis and treatment of affective disorders beyond classical neurobiological models. It includes a meta-analysis comparing single- versus two-dose psilocybin administration in major depressive disorder, clarifying its efficacy and dose-dependency. Another study uses network analysis of exposome scores to link environmental exposure with multidimensional psychopathology in non-clinical samples, while the effects of light pollution on affective health highlight chronobiological disruption in mood disorder etiology.Diagnostic and clinical dimensions are explored through research on polarity at bipolar disorder onset, mapping temperamental correlates and long-term trajectories. Biomarker studies report elevated mature brain-derived neurotrophic factor (BDNF) levels associated with suicidal ideation in major depressive disorder and evaluate BDNF's validity in bipolar disorder. Perinatal and familial aspects are explored in a structural equation modeling study showing how attachment-related coping mediates postpartum depressive symptoms and which develops a protocol for a randomized clinical trial for a psychoeducational family intervention in major depressive disorder. Together, these contributions outline a multidimensional landscape integrating environmental, temperamental, biological, and psychosocial determinants.
Da: preigu, Osnabrück, Germania
EUR 90,55
Quantità: 5 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Future Challenges for the Diagnosis and Management of Affective Disorders | From Preclinical Evidence to Clinical Trials | Buch | Englisch | 2026 | MDPI AG | EAN 9783725860715 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.